ArticleMedical oncology (Northwood, London, England)2016

Targeting tumor hypoxia with the epigenetic anticancer agent, RRx-001: a superagonist of nitric oxide generation.

Marcel H Fens et al.PubMed ↗Publisher ↗

No numbers read from the abstract.